Please select the option that best describes you:

What induction regimen would you choose for a patient with newly diagnosed multiple myeloma with incidental amyloidosis noted on bone marrow biopsy, but with no end-organ damage as a result of amyloid deposition?  

Would you consider Dara-CyBorD or a MM triplet/quadruplet such as VRd or Dara-VRd? 



Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
Love this super helpful answer! Yes, this is exact...
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
Absolutely - agreed on all fronts, especially the ...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
Agreed - this has been a fascinating discussion on...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
Thank you, @Erica L. Campagnaro! I hadn't heard of...
Sign in or Register to read more